Area of research
Psychiatry and Mental health · Molecular Biology
Research interest
Research interests include Schizophrenia research and treatment, Epigenetics and DNA Methylation, Tryptophan and brain disorders, and Genetic Associations and Epidemiology.
Pre-treatment predictors of cognitive side-effects after treatment with electroconvulsive therapy in patients with depression: A multicenter study
A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC)
Epigenome-wide association studies identify novel DNA methylation sites associated with PTSD: a meta-analysis of 23 military and civilian cohorts
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
Serum immune markers and transition to psychosis in individuals at clinical high risk
In vitro modeling of the neurobiological effects of glucocorticoids: A review
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking
Polygenic risk scores for predicting outcomes and treatment response in psychiatry: hope or hype?
Blood miR-144-3p: a novel diagnostic and therapeutic tool for depression
Nongenetic Factors Associated With Psychotic Experiences Among UK Biobank Participants
Gender differences in the association between environment and psychosis
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case–Control Study
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
Exposome and Trans-syndromal Developmental Trajectories Toward Psychosis
Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia
DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
Estimating Aggregate Environmental Risk Score in Psychiatry: The Exposome Score for Schizophrenia
Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association—The Example of Cannabis and Psychosis
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings From the Multinational EU-GEI Study
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
Sex-Specific Role for SLIT1 in Regulating Stress Susceptibility
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis
Longitudinal associations between alcohol use, smoking, genetic risk scoring and symptoms of depression in the general population: a prospective 6-year cohort study
Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness